Agena Bioscience

Agena Bioscience is proud to collaborate with our distribution partner, EXSA SRL, and its CEO, Ezequiel Boezio, in our mission to broaden the use of our cost-effective, targeted molecular analysis portfolio. Joe Balsanek and Brandon Franklin, PhD from Agena’s Business Development group recently joined EXSA for a highly productive and engaging meeting with the team from Centro Rossi in Argentina. Thank you to Centro Rossi for being such gracious hosts! We look forward to a fruitful partnership and working closely with both teams to expand molecular insights within the country. #MolecularAnalysis #Partnership #AgenaBioscience

Exciting News for PGx in California! We are thrilled to announce that California Governor Gavin Newsom has signed the UPGRADE Act into law, making pharmacogenomic (PGx) testing a covered benefit under Medi-Cal starting July 1, 2024! This landmark legislation is a significant step towards personalized medicine, reducing trial and error in medication management, and improving safety and care quality. This law can reasonably be expected to have the effect of encouraging more research in the field of PGx. Key Highlights: • Effective Date: July 1, 2024 • Covered Services: PGx testing for gene-drug interactions • Flexible Sample Collection: At home, pharmacies, or health facilities This is a major victory for advancing health equity and reducing preventable adverse drug events. #PGx #Pharmacogenomics #UPGRADEAct

📸 Live from AMP Europe 2024!🌟 Visit our booth to meet our amazing team and discover how Agena is helping researchers around the globe translate genomic discoveries into targeted, cost-effective data sets. Don't miss the chance to connect with our experts and explore how your labs could benefit! #AMPEurope2024 #AgenaBioscience #MassARRAY

🌟 An Exciting Day at Agena! 🌟 We were thrilled to welcome STEM educators from middle and high schools across the San Diego area to Agena for an immersive and informative experience. Throughout the day, we provided these dedicated teachers with an opportunity to explore various career opportunities in STEM that their students can aspire to. Our agenda included: 🔹 Engaging conversations with some of our scientists and engineers 🔹 Insightful lab tours showcasing our technology 🔹 Hands-on experiences that brought STEM concepts to life By empowering educators with knowledge and resources, we aim to inspire the next generation of scientists, engineers, and innovators. #STEM #FutureInnovators #CareerExploration #AgenaBioscience

🚀 Exciting News! 🚀    We are thrilled to announce our participation in AMP Europe 2024, where we will be featuring an insightful presentation by the esteemed Dr. Pierre-Jean Lamy from Labosud-Ocbiologie, Imagenome, Montpellier, France.    🔬 Topic: Integrating ctDNA Analysis for Targeted Therapy in Metastatic Breast Cancer    Metastatic breast cancer (mBC) treatment is evolving rapidly, driven by advances in research and understanding the molecular mechanisms behind cancer progression. Dr. Lamy will delve into the critical role of ctDNA (circulating tumor DNA) analysis in identifying and monitoring key mutations like PIK3CA, AKT, and ESR1, which are pivotal in targeted therapy research.    Traditional biopsy methods often fall short, especially with HR+ mBC patients who develop bone metastases. In this session, Dr. Lamy will discuss the advantages of liquid biopsy as a minimally invasive alternative and explore the debate between using NGS (Next-Generation Sequencing) versus targeted genotyping methods. Key considerations such as sensitivity, turn-around time, and cost will also be covered.    Join us to gain valuable insights into the future of cancer treatment research and the latest innovations in ctDNA analysis.    📅 Date: Tuesday, 25 June 🕒 Time: 13:00-14:00 📍 Location: Madrid, Spain    Can’t attend but still want to connect with an Agena representative? Visit https://lnkd.in/gGxWY4gJ and we will be happy to assist you.    #AMPEurope2024 #CancerResearch #ctDNA #MetastaticBreastCancer #LiquidBiopsy  

Greetings from ASCO 2024! We're thrilled to be here, at booth #37155, talking to attendees about their challenges with oncology molecular research and how MassARRAY® can help. Come by and chat with us to see how our solutions can improve your lab's workflow and help you navigate your challenging sample types. Whether you're interested in our mutation profiling or liquid biopsy oncology research solutions, we are here to support your lab’s needs. 🔗 Learn more about our technologies: www.agenabio.com   #ASCO2024 #CancerResearch #MassARRAY #AgenaBioscience 

Agena Bioscience will be exhibiting at the ASCO 2024 Annual Meeting! 🎉 Join us at booth #37155 to explore how our MassARRAY® technology can give you the ability to get data from your DNA in as little as 8 hours. Curious as to how? Stop by our booth to find out how we can help you transform your oncology research. See you at ASCO 2024! #ASCO2024 #Oncology #CancerResearch #MassARRAY #AgenaBioscience 

Speed and efficiency are crucial in genomics research. The MassARRAY® System’s technology offers a unique approach that combines precision with unparalleled speed, making it stand out in genetic analysis. We've put together an infographic for labs seeking to improve their genomics workflow. In this infographic you’ll learn how the MassARRAY transforms DNA to data in ~8 hours through: - A streamlined workflow with minimal hands-on time. - A single reaction with high-multiplexing capability. - Fast turnaround time and simple bioinformatics. Download Now: https://lnkd.in/g5g_DZj3

🧬✨ Happy DNA Day! ✨🧬   Today, we honor the revolutionary discoveries in DNA research and the powerful impact it has on science and health. Our cutting-edge MassARRAY® System turns DNA into data within a day, powering research labs around the world with rapid, reliable data outputs.   Let's keep unlocking the secrets of DNA together!   Explore how we transform DNA to data at www.agenabio.com   #DNADay #Genetics #AgenaBioscience #InnovationInDNA

Agena Bioscience was thrilled to be among the exhibitors at this year’s Second Annual Precision Oncology Symposium, hosted by the Baptist Health South Florida CME Department, Baptist Health Foundation, and Miami Cancer Institute. Thank you to everyone who stopped by to learn about how Agena is advancing precision oncology research. We're already looking forward to next year! #PrecisionOncology #Oncology #CancerResearch #AgenaBioscience